Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite ongoing research, surgical resection remains the only potentially curative treatment. Therefore, accurate identification of those patients who would benefit from surgical resection is of paramount importance. High-quality imaging and image interpretation is central to this process. Radiology helps in the determination of whether patients are resectable, borderline resectable, or unresectable and guides treatment planning.
Original language | English (US) |
---|---|
Pages (from-to) | 301-313 |
Number of pages | 13 |
Journal | Abdominal Radiology |
Volume | 43 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2018 |
Keywords
- Pancreatic ductal adenocarcinoma (PDAC)
- Preoperative staging
- Resectability
- Vasculature
ASJC Scopus subject areas
- Radiological and Ultrasound Technology
- Radiology Nuclear Medicine and imaging
- Gastroenterology
- Urology